Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Apical bumetanide-sensitive Na(+)-K(+)-2Cl(-) co-transporter, termed
NKCC2
, is the major salt transport pathway in kidney thick ascending limb.
NKCC2
surface expression is subject to regulation by intracellular protein trafficking. However, the protein partners involved in the intracellular trafficking of
NKCC2
remain unknown. Moreover, studies aimed at under-standing the post-translational regulation of
NKCC2
have been hampered by the difficulty to express
NKCC2
protein in mammalian cells. Here we were able to express
NKCC2
protein in renal epithelial cells by tagging its N-terminal domain. To gain insights into the regulation of
NKCC2
trafficking, we screened for interaction partners of
NKCC2
with the yeast two-hybrid system, using the C-terminal tail of
NKCC2
as bait. Aldolase B was identified as a dominant and novel interacting protein. Real time PCR on renal microdissected tubules demonstrated the expression of aldolase B in the thick ascending limb. Co-immunoprecipitation and co-immunolocalization experiments confirmed
NKCC2
-
aldolase
interaction in renal cells. Biotinylation assays showed that
aldolase
co-expression reduces
NKCC2
surface expression. In the presence of
aldolase
substrate, fructose 1,6-bisphosphate,
aldolase
binding was disrupted, and
aldolase
co-expression had no further effect on the cell surface level of
NKCC2
. Finally, functional studies demonstrated that
aldolase
-induced down-regulation of
NKCC2
at the plasma membrane was associated with a decrease in its transport activity. In summary, we identified aldolase B as a novel
NKCC2
binding partner that plays a key role in the modulation of
NKCC2
surface expression, thereby revealing a new regulatory mechanism governing the co-transporter intracellular trafficking. Furthermore,
NKCC2
protein expression in mammalian cells and its regulation by protein-protein interactions, described here, may open new and important avenues in studying the cell biology and post-transcriptional regulation of the co-transporter.
...
PMID:NKCC2 surface expression in mammalian cells: down-regulation by novel interaction with aldolase B. 1784 80